A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors

M. C. Walker, R. G. Kurumbail, J. R. Kiefer, K. T. Moreland, C. M. Koboldt, P. C. Isakson, K. Seibert, J. K. Gierse

Research output: Contribution to journalArticlepeer-review

83 Scopus citations

Abstract

Cyclo-oxygenase (COX) enzymes are the targets for non-steroidal anti-inflammatory drugs (NSAIDs). These drugs demonstrate a variety of inhibitory mechanisms, which include simple competitive, as well as slow binding and irreversible inhibition. In general, most NSAIDs inhibit COX-1 and -2 by similar mechanisms. A unique class of diarylheterocyclic inhibitors has been developed that is highly selective for COX-2 by virtue of distinct inhibitory mechanisms for each isoenzyme. Several of these inhibitors, with varying selectivity, have been utilized to probe the mechanisms of COX inhibition. Results from analysis of both steady-state and time-dependent inhibition were compared. A generalized mechanism for inhibition, consisting of three sequential reversible steps, can account for the various types of kinetic behaviour observed with these inhibitors.

Original languageEnglish
Pages (from-to)709-718
Number of pages10
JournalBiochemical Journal
Volume357
Issue number3
DOIs
StatePublished - Aug 1 2001

Keywords

  • Celecoxib
  • Meloxicam
  • PGH synthase
  • Prostaglandin
  • Valdecoxib

Fingerprint

Dive into the research topics of 'A three-step kinetic mechanism for selective inhibition of cyclo-oxygenase-2 by diarylheterocyclic inhibitors'. Together they form a unique fingerprint.

Cite this